Guidelines for the restart of imiglucerase in patients with Gaucher disease: Recommendations from the European Working Group on Gaucher disease-Reference-Cited by-同舟云学术

Guidelines for the restart of imiglucerase in patients with Gaucher disease: Recommendations from the European Working Group on Gaucher disease

Published:2010-02 Issue:2 Volume:44 Page:86-87
ISSN:1079-9796
Container-title:Blood Cells, Molecules, and Diseases
language:en
Short-container-title:Blood Cells, Molecules, and Diseases

Author:

Hollak Carla E.M.,Aerts Johannes M.F.G.,Belmatoug Nadia,Bembi Bruno,Bodamer Olaf,Cappellini Domenica,Collin-Histed Tanya,Cox Timothy M.,Deegan Patrick,Giraldo Pilar,Hughes Derralynn,Lukina Elena,Manuel Jeremy,Michelakakis Helen,Di Rocco Maja,Vellodi Ashok,Zimran Ari

Publisher

Elsevier BV

Subject

Cell Biology,Hematology,Molecular Biology,Molecular Medicine

Reference2 articles.

1. Force Majeure: therapeutic measures in response to restricted supply of imiglucerase (Cerezyme) for patients with Gaucher disease;Hollak;Blood Cells Mol. Dis.,2009

2. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm190400.htm.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacoeconomic analysis of taliglucerase alfa used in the Russian Federation for Gaucher’s disease;Medical Technologies. Assessment and Choice;2021

2. Diagnosis features of pediatric Gaucher disease patients in the era of enzymatic therapy, a national-base study from the Spanish Registry of Gaucher Disease;Orphanet Journal of Rare Diseases;2017-05-03

3. Safety and efficacy of velaglucerase alfa in Gaucher disease type 1 patients previously treated with imiglucerase;American Journal of Hematology;2013-01-22

4. Early access experience with VPRIV®: Recommendations for ‘core data’ collection;Blood Cells, Molecules, and Diseases;2011-08

5. Nonprecipitous changes upon withdrawal from imiglucerase for Gaucher disease because of a shortage in supply;Blood Cells, Molecules, and Diseases;2011-01